Skip to Main Content

Paper Details

Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.
Neuro Oncol
4
2023
Hearing loss, NF2, NF2-SWN, NF2-related schwannomatosis, Participants, SWN, VS, bevacizumab, children, hearing loss, participants, persons, progressive vestibular schwannoma, tinnitus, tumor, vestibular schwannomas
Author NameAffiliation
Jeffrey C Allen
Girish DhallUniversity of Southern California
Michael J FisherThe Children's Hospital of Philadelphia
Rakesh K JainMassachusetts General Hospital and Harvard Medical School
Roger J PackerChildren's National Medical Center
Roger J PackerChildren's National Medical Center
Matthias A Karajannis
Jaishri O BlakeleyJohns Hopkins University
  • 1 - 8

Datasets

Release 1.2